1993
DOI: 10.1093/bja/71.1.86
|View full text |Cite
|
Sign up to set email alerts
|

Signal Transduction: G Proteins and Second Messengers

Abstract: The mechanisms underlying receptor-effector coupling are fundamental to our understanding of cellular function. A central issue in this area is how cell surface receptors transduce and amplify incoming signals. Other articles in this issue of the Journal cover the details of Ca 2+ channel structure and their interactions with anaesthetic agents. This review concentrates on two of the most well characterized second messenger systems, adenylyl cyclase-cAMP and inositol polyphosphate-[Ca 2+ ][.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
9
0
1

Year Published

1994
1994
2004
2004

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 32 publications
(11 citation statements)
references
References 62 publications
1
9
0
1
Order By: Relevance
“…This is also consistent with recent studies in a variety of cell types demonstrating that some, but not all, muscarinic receptor subtypes are coupled to inositol phospholipid-specific phospholipase C (PLC) (see [23]). Activation of this pathway leads to the release of 1,4,5-IP 3 into the cytosol, where it mobilizes intracellular stores of Ca 2 + until it is phosphorylated to form 1,3,4,5-IP 4 and/or is dephosphorylated to form various inactive metabolites (see [11]).…”
Section: Discussionsupporting
confidence: 92%
“…This is also consistent with recent studies in a variety of cell types demonstrating that some, but not all, muscarinic receptor subtypes are coupled to inositol phospholipid-specific phospholipase C (PLC) (see [23]). Activation of this pathway leads to the release of 1,4,5-IP 3 into the cytosol, where it mobilizes intracellular stores of Ca 2 + until it is phosphorylated to form 1,3,4,5-IP 4 and/or is dephosphorylated to form various inactive metabolites (see [11]).…”
Section: Discussionsupporting
confidence: 92%
“…Possible sites of the action of anesthetics in the GPCR-mediated signal transduction pathway are divided into four target groups: 1) agonistreceptor binding, 2) G protein function, 3) effector activity (adenylate cyclase), and 4) other intracellular sites (e.g., Ca 2ϩ stores and cellular kinases) (Lambert, 1993). There are no previous reports demonstrating an effect of volatile anesthetics on CGRP receptor-mediated signal transduction, although several studies reported that volatile anesthetics affect the signal transduction pathway mediated by other GPCRs.…”
Section: The Effects Of Volatile Anesthetics On Cgrp Receptor-mediatementioning
confidence: 99%
“…It would also phosphorylate the NMDA-associated ion channel (101-104), relieving the magnesium block and resulting in an enhancement of NMDA receptor activity, allowing a greater influx of calcium. Increased concentrations of intracellular calcium would promote influx of calcium via voltage-gated calcium channels (101)(102)(103), and further increasing the intracellular concentration of calcium. Increased concentrations of calcium may facilitate activation of calcium/calmodulindependent protein kinases, leading to further phosphorylation and desensitization of mu-opioid receptors (81,105), as well as leading to the activation of adenylate cyclase and increased production of cAMP (103,106).…”
Section: Glutamate and Opioid Tolerance And Dependencementioning
confidence: 99%
“…Activated PKC phosphorylates opioid receptors (96-100), leading to receptor desensitization and reduced efficacy of opioid agonist analgesics. In addition, PKC phosphorylates the NMDA-associated ion channel (101)(102)(103)(104), increasing NMDA receptor activity, and leads to increased influx of calcium. The increased intracellular concentrations of calcium produce a positive feedback loop, increasing activity of protein kinases and enhancing the phosphorylation of opioid receptors and the NMDA ion channel.…”
Section: Glutamate and Neuropathic Painmentioning
confidence: 99%